These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Cutaneous Lupus: A Brief Review of Old and New Medical Therapeutic Options. Nutan F; Ortega-Loayza AG J Investig Dermatol Symp Proc; 2017 Oct; 18(2):S64-S68. PubMed ID: 28941497 [TBL] [Abstract][Full Text] [Related]
14. Combined mepacrine-hydroxychloroquine treatment in patients with systemic lupus erythematosus and refractory cutaneous and articular activity. Ugarte A; Porta S; Ríos R; Martinez-Zapico A; Ortego-Centeno N; Agesta N; Ruiz-Irastorza G Lupus; 2018 Sep; 27(10):1718-1722. PubMed ID: 29635998 [TBL] [Abstract][Full Text] [Related]
15. Antimalarials in cutaneous lupus erythematosus: mechanisms of therapeutic benefit. Wozniacka A; Carter A; McCauliffe DP Lupus; 2002; 11(2):71-81. PubMed ID: 11958581 [TBL] [Abstract][Full Text] [Related]
16. [Subacute cutaneous lupus. Evolutive and therapeutic features of a series of 24 cases]. Versapuech J; Beylot-Barry M; Doutre MS; Beylot C Presse Med; 2000 Oct; 29(29):1596-9. PubMed ID: 11072357 [TBL] [Abstract][Full Text] [Related]